Credo: Fantastic Growth Drivers Ahead Make This A Buy (Archive) CRDO levered to AI data centers, expanding beyond its flagship product of active electrical cables with underpriced growth and valuation tailwinds.
Sempra: A Safe Utility Way To Ride The Data Center Power Boom Regulated rate-base growth, asset-sale-funded capex, and strong momentum support upside.
Exxon Mobil: Boosted By Powerful Pricing And Volume Tailwinds (Archive) Exxon Mobil rides war‑driven oil prices and low‑cost volume growth in a powerful uptrend.
Meta: A Deeper Look At Its Capex Burdens (Archive) Meta’s rising self-funded power infrastructure and youth social-media bans create mounting, underappreciated headwinds.
CrowdStrike And The AI Agents Cyber Threat (Archive) AI agents erode CrowdStrike’s moat as growth, valuation and technicals all turn bearish.
Otsuka Holdings: New FDA‑Backed Kidney Drug Could Ignite a Multi‑Year Rally FDA-backed kidney breakthrough and ADHD catalyst support Otsuka’s breakout despite looming patent cliffs.
Micron Says Go Big Or Go Home As It Ramps Up Capex Far More Than Peers (Archive, Full Access) Micron’s AI memory bonanza is compelling, but aggressive capex keeps the rating at Hold.